Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-25 @ 3:04 AM
NCT ID:
NCT00120133
Eligibility Criteria:
Inclusion Criteria:
* Children with various metabolic bone diseases and osteoporosis who are to initiate treatment with either pamidronate and/or zoledronic acid.
* They should be 6 to 25 years old, able to understand the study, swallow pills and competent to complete the visual analogue pain scale.
Exclusion Criteria:
* Children less than 6 years old or incompetent to complete the visual analogue pain scale.
* Children with seizure disorder associated or triggered by fever.
* Children known to have hypersensitivity reaction to statins, active liver disease or persistent elevated serum transaminases or CPK.
* Children on erythromycin, cyclosporine, fibric acid, azole antifungals, cimetidine and spironolactone will be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
25 Years
Study:
NCT00120133
Study Brief:
Protocol Section:
NCT00120133